Our experiments with concomitant embryonic inactivation of Robo2 and mutant Kras activation (KC_Robo2F/F) followed by chronic pancreatitis show no additional phenotypic changes compared to controls. The gene discussed is KRAS; the disease is chronic pancreatitis.